Clinical Trials Logo
  1. Home
  2. Chronic Pain
  3. NCT05687929
  4. Details
NCT05687929 Clinical Trial

Real-World Registry Study on Clinical Analgesic Effect of Acetylaconitine Tablets

Chronic Pain Clinical Trial

Official title:
Real-World Registry Study on Clinical Analgesic Effect of Acetylaconitine Tablets

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT05687929
Other study ID # XH-22-008
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date March 27, 2023
Est. completion date December 15, 2024

Study information
Verified date April 2024
Source Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Contact Ma Ke, doctor
Phone 13361879260
Email marke72@163.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

1. To observe the clinical analgesic effect, safety and adverse reactions of acetylaconitine. 2. To study and analyze the main influencing factors of the acetylaconitine tablets.

Description:

The outpatients/inpatients meeting the criteria are included into this study after signing the Informed Consent Form. The patients received 5 visits in total, which take place after the patients are included into the real-world study, on the 3rd day after enrollment and at the 1st, 4th, 8th and 12th weeks thereafter, in the form of outpatient follow-up, telephone follow-up and APP follow-up.

Recruitment information / eligibility
Status Recruiting
Enrollment 3500
Est. completion date December 15, 2024
Est. primary completion date June 15, 2023
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Patients with chronic pain > 1 month and VAS > 40 mm Patients who can take the acetylaconitine tablets orally Exclusion Criteria: - Patients who cannot communicate or receive follow-up Patients allergic to acetylaconitine Patients who have taken the acetylaconitine drugs orally

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
China The Third Xiangya Hospital of Central South University Changsha Hunan

Sponsors (1)
Lead Sponsor Collaborator
Ke Ma

Country where clinical trial is conducted

China, 

Outcome
Type Measure Description Time frame Safety issue
Primary VAS (0-100mm), IDpain Pain score December 2022 to December 2023
See also
  Status Clinical Trial Phase
Completed NCT01659073 - Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation N/A
Recruiting NCT05914311 - Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration N/A
Recruiting NCT05422456 - The Turkish Version of Functional Disability Inventory
Enrolling by invitation NCT05422443 - The Turkish Version of Pain Coping Questionnaire
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04385030 - Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury N/A
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05103319 - Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
Completed NCT03687762 - Back on Track to Healthy Living Study N/A
Completed NCT04171336 - Animal-assisted Therapy for Children and Adolescents With Chronic Pain N/A
Completed NCT03179475 - Targin® for Chronic Pain Management in Patients With Spinal Cord Injury Phase 4
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Completed NCT03268551 - MEMO-Medical Marijuana and Opioids Study
Recruiting NCT06060028 - The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain N/A
Recruiting NCT06204627 - TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain N/A
Completed NCT05496205 - A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers Phase 1
Completed NCT00983385 - Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics Phase 3
Recruiting NCT05118204 - Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization Phase 4
Terminated NCT03538444 - Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder N/A
Not yet recruiting NCT05812703 - Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain